4//SEC Filing
EAGLE PHARMACEUTICALS, INC. 4
Accession 0001209191-17-002685
CIK 0000827871operating
Filed
Jan 5, 7:00 PM ET
Accepted
Jan 6, 5:08 PM ET
Size
5.6 KB
Accession
0001209191-17-002685
Insider Transaction Report
Form 4
Pernock David
Director
Transactions
- Award
Stock Option (right to buy)
2017-01-04+90,000→ 90,000 totalExercise: $84.92Exp: 2027-01-03→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The option vests over a period of four years, with 25% of the shares underlying the option vesting on January 4, 2018, the first anniversary of the date of grant, and the remainder vesting in 36 equal monthly installments thereafter, subject to the reporting person's continuous service with the issuer as of the applicable vesting date.
Documents
Issuer
EAGLE PHARMACEUTICALS, INC.
CIK 0000827871
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000827871
Filing Metadata
- Form type
- 4
- Filed
- Jan 5, 7:00 PM ET
- Accepted
- Jan 6, 5:08 PM ET
- Size
- 5.6 KB